ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: DOD releases PA On Ovarian Cancer

August 6, 1999

NCI To Offer Planning Grants for New Centers

November 9, 1990

In Brief: Pazdur to direct FDA Oncology Division; Ganz Awarded ACS Clinical Professorship

July 23, 1999

NCI To Merge Two Intramural Divisions To Form Center For Cancer Research.

January 12, 2001

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

Fisher Seeks Damages Under Privacy Act; NIH Consents To Remove Database Flags

March 10, 1995